These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16631737)

  • 21. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease.
    Li H; Guo Z; Jiang X; Zhu H; Li X; Mao N
    Stem Cells; 2008 Oct; 26(10):2531-41. PubMed ID: 18635870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells.
    Bian L; Guo ZK; Wang HX; Wang JS; Wang H; Li QF; Yang YF; Xiao FJ; Wu CT; Wang LS
    In Vivo; 2009; 23(1):21-7. PubMed ID: 19368120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
    Ye Z; Wang Y; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
    Mishra PK
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplanted mesenchymal stem cells can inhibit the three developmental stages of murine acute graft-versus-host disease.
    Li H; Guo Z; Zhu H; Li XS; Jiang X; Yao H; Wang X; Liao L; Liu Y; Wu Y; Zhang Y; Mao N
    In Vivo; 2010; 24(5):659-66. PubMed ID: 20952730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
    Augello A; Tasso R; Negrini SM; Amateis A; Indiveri F; Cancedda R; Pennesi G
    Eur J Immunol; 2005 May; 35(5):1482-90. PubMed ID: 15827960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells.
    Selmani Z; Naji A; Gaiffe E; Obert L; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
    Transplantation; 2009 May; 87(9 Suppl):S62-6. PubMed ID: 19424010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling.
    Gur-Wahnon D; Borovsky Z; Beyth S; Liebergall M; Rachmilewitz J
    Exp Hematol; 2007 Mar; 35(3):426-33. PubMed ID: 17309823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways.
    Kim JA; Hong S; Lee B; Hong JW; Kwak JY; Cho S; Kim CC
    Cell Immunol; 2007 Jan; 245(1):16-23. PubMed ID: 17470365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antheraea pernyi silk fibroin maintains the immunosupressive properties of human bone marrow mesenchymal stem cells.
    Luan XY; Huo GH; Li MZ; Lu SZ; Zhang XG
    Cell Biol Int; 2009 Nov; 33(11):1127-34. PubMed ID: 19664716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells.
    Piccirillo CA; Thornton AM
    Trends Immunol; 2004 Jul; 25(7):374-80. PubMed ID: 15207505
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules.
    Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G
    Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.